PlainRecalls
FDA Drug Moderate Class II Ongoing

Clindamycin HCl, 300 mg Capsule, QTY: 30 Capsules per bottle, Rx Only, Repackaged by: RemedyRepack Inc., Indiana, PA 15701. NDC; 70518-3772-00

Reported: April 30, 2025 Initiated: March 24, 2025 #D-0378-2025

Product Description

Clindamycin HCl, 300 mg Capsule, QTY: 30 Capsules per bottle, Rx Only, Repackaged by: RemedyRepack Inc., Indiana, PA 15701. NDC; 70518-3772-00

Reason for Recall

CGMP Deviations

Details

Recalling Firm
RemedyRepack Inc.
Units Affected
1,858 30-count blister cards
Distribution
PA
Location
Indiana, PA

Frequently Asked Questions

What product was recalled?
Clindamycin HCl, 300 mg Capsule, QTY: 30 Capsules per bottle, Rx Only, Repackaged by: RemedyRepack Inc., Indiana, PA 15701. NDC; 70518-3772-00. Recalled by RemedyRepack Inc.. Units affected: 1,858 30-count blister cards.
Why was this product recalled?
CGMP Deviations
Which agency issued this recall?
This recall was issued by the FDA Drug on April 30, 2025. Severity: Moderate. Recall number: D-0378-2025.